Aslıhan DOĞRU -TDO- A trial in his case against The European Union (EU) AstraZeneca in April for failing to deliver the new type of coronavirus (Covid-19) vaccines it has committed to was held in Brussels on 26 May.
The EU side's lawyer has asked the court to award him hefty damages for failing to comply with the firm's agreement with the union.
Swedish/British pharmaceutical and biotechnology firm AstraZeneca delivered 50 million doses of vaccines to the EU in early May.
That's only a quarter of the 200 million doses included in the contract.
AstraZeneca's lawyer, speaking at the hearing, stressed the difficulties in producing vaccines, stating that the product in question was not shoes or T-shirts.
A lawyer for AstraZeneca said the EU's accusations were shocking, adding that the company calculated its delivery target based on early estimates of production capacity and sold the vaccine at the cost of production.